top of page
Dense Breasts: Why a Mammogram Alone May Not Be Enough, and Which Supplemental Screening Helps

Dense Breasts: Why a Mammogram Alone May Not Be Enough, and Which Supplemental Screening Helps

ป้าหมอนุช
1 hour ago
3 min read

Dense breasts have more glandular and connective tissue than fat. About 40–50% of women have dense breasts, more often Asian and younger women. Density matters for two reasons: cancer is harder to see on mammograms, because both dense tissue and cancer appear white, and density itself raises breast cancer risk. Supplemental screening finds additional cancers. At Namarak Hospital, 3D mammography, ultrasound and automated breast ultrasound (ABUS) can be done in a single visit as appropriate, with MRI at carefully selected, quality-assured partner hospitals when indicated.

Breast density categories (BI-RADS)

  • A — almost entirely fatty

  • B — scattered areas of fibroglandular density

  • C — heterogeneously dense, which may hide small masses

  • D — extremely dense, which greatly lowers mammogram sensitivity

Categories C and D are considered dense. Density can only be assessed on a mammogram — not by feel or breast size. Since 2024, U.S. regulations require every mammogram report to tell women their breast density — see Understanding BI-RADS

Supplemental screening for dense breasts

  • [3D mammography (tomosynthesis)](https://www.namarak.com/en/post/3d-mammogram-1) — thin-slice images reduce tissue overlap, finding more cancers with fewer recalls than 2D

  • Handheld ultrasound — finds about 2–4 additional cancers per 1,000 women screened, without radiation — see Breast ultrasound

  • Automated breast ultrasound (ABUS) — scans the whole breast into standardized 3D images that are easy to compare over time

  • Breast MRI — the most sensitive test; the DENSE trial showed that adding MRI in extremely dense breasts cut interval cancers by more than half; suited to high-risk women or extremely dense breasts — see Breast MRI

  • Contrast-enhanced mammography — a newer option with sensitivity close to MRI, but indications are still limited; Namarak does not currently offer it because the more sensitive MRI can be arranged when indicated

Who should have which test?

  • Dense breasts, average risk — yearly 3D mammography with ultrasound or ABUS

  • Extremely dense breasts (D) — the American College of Radiology recommends considering supplemental MRI where available

  • High risk (e.g. BRCA carriers, lifetime risk of 20% or more, chest radiation before 30) — yearly MRI with mammography; under the Thai guideline, mammography with ultrasound may be alternated with MRI

  • Start screening according to age and risk — see Breast cancer screening

Can density or risk be reduced?

  • Density is largely genetic and age-related, and falls with age and after menopause

  • Menopausal hormone therapy may increase density

  • Tamoxifen lowers density in women taking it for risk reduction

  • Exercise, weight control and limiting alcohol lower overall cancer risk — see Risk factors and prevention

Frequently asked questions (FAQ)

How do I know if I have dense breasts?

Only from your mammogram report, which grades density from A to D; C and D are dense. Feel or breast size cannot tell.

Are dense breasts a disease?

No. Dense breasts are a normal finding in about half of women, but they make cancer harder to see on mammograms and modestly raise risk.

What extra tests do dense breasts need?

3D mammography with ultrasound or automated breast ultrasound (ABUS) is recommended; women with extremely dense breasts or high risk may consider supplemental MRI.

Can ultrasound replace mammography?

No. Ultrasound does not show tiny calcifications well, which are often the first sign of stage 0 cancer, so it supplements rather than replaces mammography.

How is ABUS different from regular ultrasound?

ABUS uses a large transducer to automatically scan the whole breast into standardized 3D images, which radiologists can review and compare with previous scans easily.

About Namarak Hospital

Namarak Hospital is a specialized breast and breast cancer hospital in Bangkok, providing complete care in one place — from diagnosis with 3D mammography, ultrasound, automated breast ultrasound (ABUS) and biopsy to comprehensive breast cancer treatment, including breast-conserving and reconstructive surgery, intraoperative radiotherapy (IORT), chemotherapy, targeted therapy and endocrine therapy, planned by a multidisciplinary team according to the latest international guidelines. See Breast cancer treatment: a complete guide, contact us on LINE, tel. +66 2 059 0245, or our Second Opinion service.

Related articles

References

  • Monticciolo DL, et al. Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR. J Am Coll Radiol 2023;20:902–14

  • Bakker MF, et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue (DENSE). N Engl J Med 2019;381:2091–102

  • Berg WA, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk (ACRIN 6666). JAMA 2012;307:1394–404

  • U.S. Food and Drug Administration. Mammography Quality Standards Act final rule: breast density notification, effective September 10, 2024

  • American College of Radiology. ACR BI-RADS Atlas, 5th ed. 2013

Medically reviewed by: Namarak Hospital medical team · Last checked: 17 November 2026 · This information is for general education and is not individual medical advice. Please consult your doctor for diagnosis and treatment suited to you.

Comments


Link to the Namarak Hospital medical team profiles
bottom of page